Corporate News 07-Mar-19
Marksans Pharma's Goa facility concludes USFDA inspection with 8 observations
Marksans Pharma announced that U.S. FDA has concluded inspection of Company's Goa facility. The inspection of the facility took place between 25th February to 6th March 2019, resulting in a Form 483 with eight observations. None of these observations are considered either critical or repetitive in nature. Company is highly confident of closing these expeditiously and remains commited to global standards of quality & compliance. The site will continue to supply to the US markets all approved ANDA's. This inspection will help Company to receive pending ANDA's approval already filed by it.
Previous News
Marksans Pharma jumps on raising funds via conversion of warrants
( Hot Pursuit - 20-Jan-23 11:03 )
Board of Marksans allots 5.03 cr equity shares on conversion of warrants
( Corporate News - 20-Jan-23 10:01 )
Marksans Pharma reports consolidated net profit of Rs 8.58 crore in the March 2019 quarter
( Results - Announcements 29-May-19 17:24 )
Marksans Pharma subsidiary recalls drugs for packaging issue
( Corporate News - 21-Jun-22 12:11 )
Board of Marksans Pharma recommends final dividend
( Corporate News - 30-May-24 16:01 )
Marksans Pharma standalone net profit declines 97.28% in the June 2016 quarter
( Results - Announcements 14-Aug-16 10:25 )
Marksans Pharma to announce Quarterly Result
( Corporate News - 01-Feb-19 10:50 )
Marksans Pharma jumps after Q3 PAT climbs 34% YoY to Rs 83 cr
( Hot Pursuit - 13-Feb-24 15:41 )
Indo Count Industries Ltd leads gainers in 'A' group
( Hot Pursuit - 04-Jul-18 12:00 )
Board of Marksans Pharma approves issue of convertible warrants
( Corporate News - 15-Jun-21 15:01 )
Marksans Pharma reports net profit of Rs 14.40 crore in the September 2012 quarter
( Results - Announcements 12-Nov-12 21:42 )
Other Stories
Tinna Trade raises Rs 49 cr to fund its growth plans
06-Jul-24 11:10
Integra Essentia announces merger with G G Engineering
06-Jul-24 11:05
Ugro Capital to raise Rs 75 cr via NCD issuance
06-Jul-24 10:58
Board of D.P. Abhushan approves preferential allotment of shares and warrants
06-Jul-24 10:50
Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
06-Jul-24 10:49
High Energy Batteries (India) to discuss results
06-Jul-24 10:29
Havells India schedules board meeting
06-Jul-24 10:29
Axis Bank announces board meeting date
06-Jul-24 10:29
Mastek to conduct board meeting
06-Jul-24 10:29
Oriental Hotels to conduct board meeting
06-Jul-24 10:29
Back
Top
